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Abstract
Introduction: Fibromyalgia is difficult to treat and requires the use of multiple approaches. This study is a
randomized controlled trial of qigong compared with a wait-list control group in fibromyalgia.
Methods: One hundred participants were randomly assigned to immediate or delayed practice groups, with the
delayed group receiving training at the end of the control period. Qigong training (level 1 Chaoyi Fanhuan
Qigong, CFQ), given over three half-days, was followed by weekly review/practice sessions for eight weeks;
participants were also asked to practice at home for 45 to 60 minutes per day for this interval. Outcomes were
pain, impact, sleep, physical function and mental function, and these were recorded at baseline, eight weeks, four
months and six months. Immediate and delayed practice groups were analyzed individually compared to the
control group, and as a combination group.
Results: In both the immediate and delayed treatment groups, CFQ demonstrated significant improvements in
pain, impact, sleep, physical function and mental function when compared to the wait-list/usual care control group
at eight weeks, with benefits extending beyond this time. Analysis of combined data indicated significant changes
for all measures at all times for six months, with only one exception. Post-hoc analysis based on self-reported
practice times indicated greater benefit with the per protocol group compared to minimal practice.
Conclusions: This study demonstrates that CFQ, a particular form of qigong, provides long-term benefits in several
core domains in fibromyalgia. CFQ may be a useful adjuvant self-care treatment for fibromyalgia.
Trial registration: clinicaltrials.gov NCT00938834.
Introduction
Fibromyalgia is a chronic pain condition characterized
by widespread musculoskeletal pain of greater than
three months duration, and it is associated with fatigue
and sleep disturbance as well as other symptoms [1,2].
It affects approximately two to three percent of the
population, and leads to disability, impaired quality of
life and increased health care utilization [3,4]. Treat-
ments for fibromyalgia are focused on symptom relief
along with teaching patients self-management strategies
for living with chronic pain. Pregabalin, duloxetine and
milnacipran have been approved by the US Food and
Drug Administration for treatment of fibromyalgia [1],
but these and other pharmacological agents provide
only partial improvement. Psychological approaches [5],
exercise [6], and complementary and alternative techni-
ques [7,8] have been evaluated in fibromyalgia, and
these also provide only partial effects. The limited effec-
tiveness of single treatments has led to suggestions that
multimodal approaches are required [9,10]. Meta-analy-
sis indicates post-treatment benefits of multicomponent
treatment, but there is little evidence of efficacy in core
domains in the long-term [9]. Many individuals with
fibromyalgia continue to experience disabling pain and
fatigue over the long-term, and additional approaches
are needed.
Recent controlled trials have demonstrated that qigong
and tai chi offer benefits in fibromyalgia that persist to
four to six months [11,12]. These practices have recently
been characterized as “meditative movement”, and con-
stitute a distinct category of exercise [13]. Earlier studies
evaluating qigong for fibromyalgia involved limited
amounts of practice (one hour qigong/week) as part of
an 8-week mind-body intervention [14], an 8-week
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combined education/relaxation/qigong intervention [15]
or a 12-week body awareness therapy [16] and reported
only modest benefit. In a more recent controlled study,
daily qigong self-practice (40 minutes) was encouraged
for the duration of the seven-week program, and bene-
fits reported in several domains were maintained at four
months [11]. A further pilot trial of qigong self-practice
for nine weeks (45 minutes daily) indicated reductions
in pain and impact, and improvement in physical func-
tion for six months [17].
The current study is a randomized controlled trial
designed to compare the effects of self-practice of
qigong (45 minutes daily, eight weeks) with a control
group over a six-month interval. One hundred partici-
pants were assigned to either an immediate training
group or a wait-list control group who continued with
their usual care. At the end of six months, the wait-list
group also received training and constituted a delayed
practice group. This study design allows for two sepa-
rate treatment cohorts to be compared, as well as for




This trial was conducted from September 2009 to July
2011 at the Pain Management Unit, Queen Elizabeth II
Health Sciences Center, Halifax, Nova Scotia. The Ethics
Review Committee of the hospital approved the study
protocol. Eligible participants met the 1990 American
College of Rheumatology criteria for fibromyalgia [18];
all reported widespread pain bilaterally with pain above
and below the waist and axial skeletal pain for three
months or longer, as well as at least 11 of 18 tender
points. Medications must have been stable for at least
14 days prior to participating, and the average 7-day
pain score had to be ≥ 4.0 on an 11-point numerical rat-
ing scale. Patients were asked to practice qigong for 45
to 60 minutes per day for eight weeks once training was
complete. Participants were excluded if they were
already practitioners of qigong or if there was a signifi-
cant medical disorder that the study physician thought
would compromise participant safety.
Study design
Recruitment occurred primarily in response to advertise-
ments in the local newspaper. A total of 268 subjects
responded, 148 were screened by telephone, and 120
underwent clinic screening until 100 participants were
available for the study. Participants were assigned, using
computer generated numbers, to an immediate qigong
training group or to a control group (wait-list/usual
care), which subsequently underwent delayed training.
Randomized group assignments were sealed in opaque
white envelopes. Once participants consented to enter
the trial, envelopes were opened and assignments made
to an immediate training date or to a delayed training
time six months later. Using this design, all participants
received qigong training. There were three main training
cohorts of 20 to 30 per group, and one additional smal-
ler training group at the end for the third wait-list
group.
Qigong intervention and control group
There are many forms of qigong. The present study
examined Chaoyi Fanhuan Qigong or CFQ [19] because
it is available locally with community-based trained
practitioners, and because CFQ had shown benefits in
fibromyalgia in a pilot study [17]. Qigong training con-
sisted of an initial workshop conducted over three con-
secutive half-days by a qualified CFQ instructor.
Participants received training in level 1 CFQ; this con-
sisted of instruction in seven key movements known as
“the hexagram” and ancillary exercises. Hexagram move-
ments consist of choreographed movements that
emphasize softness, relaxation, downward releases and
full body distribution of “qi”. Once initial training was
complete, participants were asked to practice CFQ at
home for 45 to 60 minutes per day for eight weeks;
time could be broken up into shorter sessions during
the day. Participants returned for a 60 minute weekly
review/group practice sessions for these eight weeks.
Participants were then encouraged to continue self-prac-
tice for six months. Outcomes were assessed via ques-
tionnaires filled out by each patient on the day of
training (baseline) and at the eight-week review session;
four- and six-month outcomes were returned by mail.
The control group consisted of a wait-list group that
continued on with their usual care. This group com-
pleted baseline measures on the day of screening, and
returned subsequent outcomes by mail at eight weeks,
four and six months. When they returned for CFQ
training six months later, they followed the procedure
described above.
Adherence to program
Adherence to the protocol was determined by self-
reports on a qualitative questionnaire. This question-
naire was completed at eight weeks, and also at four
and six months. The mean (SD) self-reported practice
time per week for all participants who completed the
trial was 4.9 (1.7) h at eight weeks (N = 73), 2.9 (2.1) h
at four months, and 2.7 (2.1) h at six months. Approxi-
mately 52% of participants (N = 38/73) self-reported
practice of ≥ 5 h per week at eight weeks, which corre-
sponds to 45 minutes per day; practice times for this
group were 6.2 (1.1) h, 3.8 (2.0) h, and 3.3 (2.1) h at
respective time intervals. Further information in the
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qualitative reports will be analyzed and published
separately.
Outcome measures and follow-up
Assessments consisted of outcomes in several core
domains in accordance with recommendations of the
Initiative on Methods, Measurement, and Pain Assess-
ment in Clinical Trials (IMMPACT) [20]. Pain was the
primary outcome, and was measured using an 11-point
numerical rating scale for pain intensity (NRS-PI) with
anchors “no pain” and “pain as bad as you can imagine”.
Numerical rating scales have been widely used in pain
research, and have been demonstrated to identify clini-
cally meaningful changes [21].
Secondary outcome measures included the Fibromyal-
gia Impact Questionnaire (FIQ), Pittsburg Sleep Quality
Index (PSQI), and SF-36 Health Survey. The FIQ is a
10-item validated scale that assesses physical function-
ing, pain, depression, anxiety, fatigue, morning tiredness,
stiffness, job difficulty and overall well-being; it has
demonstrated reliability and validity [22]. The PSQI is a
well-validated and reliable assessment tool for measure-
ment of sleep quality in clinical populations [23]. The
SF-36 Health Survey [24] is the most commonly used
generic measure of health related quality of life and is
recommended in IMMPACT guidelines [20].
Statistical analysis
A previous trial of qigong for fibromyalgia (seven weeks,
follow-up at four months) involved 58 participants (28 to
29 per group) [11], and a more recent trial of tai chi for
fibromyalgia over six months involved 66 participants (33
per group) [12]. Both studies showed statistically signifi-
cant effects on pain, FIQ scores, and physical and psy-
chological health using these sample sizes. Because of the
commitment to practice involved in the present trial
(self-practice of 45 to 60 minutes daily for eight weeks)
and the duration of the trial (six months), whereby there
was the potential for a significant attrition, we targeted a
trial recruitment of 50 per group for 100 in total.
Statistical analysis focused on change from baseline
scores for the primary (NRS-PI), and secondary (FIQ,
PSQI, SF-36 Physical and Mental) measures. Compari-
sons of mean change scores were made between the
immediate treatment and wait-list control groups at
eight weeks, four months and six months. In order to
limit the risk of Type I error, multivariate analysis of
variance (MANOVA) was used. Mean change scores for
all subjects (combination group) who underwent train-
ing and practice were also compared to change scores
during the wait-list phase.
To evaluate the extent of clinically meaningful out-
comes, the proportion of subjects in each study group
who achieved changes from baseline that reached
previously established clinical criteria were compared
using the Chi square test.
Qigong practice times per week self-reported at Week
8 were categorized into three groups: 1) “per protocol”
where practice times were ≥ 5 hours per week, in keeping
with the recommended 45 to 60 minutes per day; 2) > 3
but < 5 hours per week; and 3) ≤ 3 hours or less per
week. This last group was considered “minimal practice”
and served as a basis of comparison with the per protocol
group to examine the relationship between practice time
and magnitude of change from baseline on each outcome
measure; this comparison was made using MANOVA.
Results
Baseline characteristics of participants
Table 1 shows baseline characteristics of participants
assigned to the immediate practice and wait-list/delayed
practice groups. Most participants (94 to 98%) were female.
The mean age at enrollment was 52 years, and the mean
duration of fibromyalgia was 9.6 years. Several additional
pain diagnoses were involved (Table 1); the incidence of
these did not differ between groups, except for orofacial
pain which was higher in the wait-list/delayed practice
group (P < 0.007). Participants had previously been treated
with several drugs from major analgesic and adjuvant drug
groups, and had also tried a variety of complementary and
alternative therapies. There was no difference in the
analgesic pharmacological profile between groups.
Figure 1 shows the flowchart for disposition of sub-
jects throughout the study. Randomization resulted in
assignment of N = 53 to the immediate, and N = 47 to
the delayed group. N = 43/53 (81.1%) completed the
immediate qigong training protocol for six months, and
N = 30/37 (81.1%) completed the delayed qigong proto-
col for six months. N = 30/47 (63.8%) completed the
wait-list protocol for six months and then the training
protocol for six months.
Pain and impact of fibromyalgia
Table 2 shows baseline values for all outcomes in the
immediate practice group, the wait-list group and then
the delayed practice group. There were no differences in
baseline values in any measure between groups. NRS-PI
scores remained relatively stable during the six-month
interval in the wait-list group (Figure 2A). There were
statistically significant reductions in pain at all times
compared to the wait-list/usual care group in both
immediate and delayed CFQ practice groups (Figure 2A).
Both groups showed similar results despite the six-month
delay in training for one group, and this indicates the
reproducibility of outcomes in two cohorts. Figure 2B
indicates change in FIQ scores from baseline. FIQ scores
were reduced by 17 to 18 units from baseline at eight
weeks in both the immediate and delayed CFQ practice
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groups; in both instances this was significantly reduced
compared to the control group (P < 0.001). While there
was a slight rebound in FIQ scores at four and six
months, significant differences were maintained in both
individual CFQ groups compared to the control group
(Figure 2B).
Sleep and physical and mental function
Sleep scores showed downward drift over six months in
the wait-list group (Figure 2C). PSQI scores were signifi-
cantly improved in both immediate and delayed CFQ
groups at eight weeks; improvements were maintained
in the immediate training group, but exhibited rebound
in the delayed group. Physical and mental function
scores remained relatively stable over six months in the
wait-list group (Figure 3A, B). Following CFQ practice,
SF-36 physical scores were significantly improved at
eight weeks and this was maintained at four and six
months in both individual groups (Figure 3A). SF-36
mental scores were also significantly improved in indivi-
dual CFQ groups at eight weeks, but did not differ from
controls at later times (Figure 3B).
Combined outcomes in two CFQ groups
When data for the immediate and delayed practice
groups were combined, the significant reductions in
Table 1 Study participants and baseline characteristics
Variable Immediate practice group Wait-list, then delayed practice group
Randomized N = 53 N = 47
Completed study (%) N = 43 (81.1%) N = 30 (63.8%)
Gender M:F (% ratio) 3:50 (6:94) 1:46 (2:98)
Age at enrollment, years (SD) 52.81 (8.91) 52.13 (8.56)
Duration of FM, years (SD) 9.67 (6.87) 9.62 (7.56)
Total tender points (IQR) 15 (14, 16) 15 (13, 16)
BMI at enrollment (IQR) 30 (25.4, 34.7) 29.4 (24.8, 34.8)
Additional pain diagnoses
Back 23 (43.3%) 21 (44.7%)
Cervical sprain 16 (30.2%) 18 (38.3%)
Diabetic neuropathy 2 (3.8%) 3 (6.4%)
Post-surgical/post-traumatic 4 (7.5%) 8 (17.0%)
Headache 31 (58.5%) 27 (57.4%)
Orofacial pain 23 (43.4%) 33 (70.2%) P < 0.007
Osteoarthritis 22 (41.5%) 17 (36.2%)
Rheumatoid arthritis 5 (9.4%) 4 (8.5%)
Other 16 (30.2%) 13 (27.7%)
Previous treatments
Anticonvulsants 14 (26.4%) 25 (53.2%)
Antidepressants 45 (84.9%) 34 (72.3%)
Nerve blocks/injections 7 (13.2%) 4 (8.5%)
NSAIDs 37 (69.8%) 36 (76.6%)
Opioids 22 (41.5%) 14 (29.8%)
Acupuncture 24 (45.3%) 24 (51.1%)
Chiropractic 11 (20.8%) 17 (36.2%)
Naturopath/Homeopath/Osteopath 17 (32.1%) 22 (46.8%)
Massage therapy 36 (67.9%) 32 (68.1%)
Physiological therapies 26 (49.1%) 23 (48.9%)
Psychological therapies 19 (35.8%) 20 (42.6%)
Current pain medications
Anticonvulsants 13 (24.5%) 14 (29.8%)
Antidepressants 20 (37.7%) 15 (31.9%)
NSAIDs 26 (49.1%) 27 (57.4%)
Opioids 19 (35.8%) 11 (23.4%)
Other 29 (54.7%) 28 (59.6%)
Total number (SD) 2.43 (1.41) 2.49 (1.59)
BMI, body mass index; IQR, interquartile range; SD, standard deviation
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pain reported at the end of the eight-week training/
practice interval (P < 0.001) were sustained in the longer
term to four months (P < 0.001) and six months (P =
0.003) (Figure 4A). With respect to FIQ scores, the
combination group exhibited significant improvements
compared to the control group at all times (two, four
and six months) (Figure 4B). There was also a signifi-
cant improvement in sleep (Figure 4C) and in physical
function (Figure 4D) at all times over the six-month
interval in the combination group. Mental function was
significantly improved at two and six months, but not at
four months (Figure 4E).
The median duration of fibromyalgia in this study was
nine years. A post-hoc analysis of those above and below
the median in the combination CFQ group indicated simi-
lar changes in pain in both cohorts (mean NRS-PI reduc-
tions of 1.38, 1.52 and 1.35 for < 9 years and 1.49, 1.35
and 1.26 for ≥ 9 years at eight weeks and four and six
months, P = 0.82, 0.77 and 0.85, respectively). Post-hoc
analysis of those with fibromyalgia for < 9 or ≥ 9 years
indicated no difference in FIQ reductions in relation to
duration of the condition (mean reduction of 16.72, 16.00
and 16.12 for < 9 years, and 19.38, 12.09 and 14.50 for ≥ 9
years at eight weeks and four and six months, P = 0.52,
0.38 and 0.73, respectively).
Clinically meaningful outcomes
Minimal clinical differences for pain (30% reduction from
baseline) [21] and FIQ (14% reduction from baseline) [25]
     
   
Participants prescreened 
by telephone  N=268
Underwent clinic evaluation
N=120
148 excluded: travel issues (24), 
scheduling conflicts (12), refusal (20),
no shows for screening appointment 
(29), no FM diagnosis (17), NRS-PI too 
low (6), existing medical conditions 
(20), other (20)
N=100 randomized to study
N=53 Immediate qigong training
20 excluded: 4 did not have FM
5 had less than 11 tender points
8 had NRS-PI of less than 4/10
3 had medical conditions physician felt 
would compromise safety in trial 
47 Wait list control group
N=44 completed 8 weeks
N=37 Delayed qigong training
1 adverse event
5 non-compliant
3 lost to follow-up
1 other (N=10)
N=43 completed 6 month 
N=45 completed 8 weeks
N=45 completed 6 month 
3 withdrew prior to 
training
5 did not complete    
training
4 non-compliant
1 lost to follow-up
2 withdrew 
(N=15)
N=32 completed 8 weeks
N=30 completed 6 months
1 withdrew
1 lost to follow-up
(N=2)
Figure 1 Screening, randomization and disposition of participants.









NRS-PI 6.45 (1.45) 6.55 (1.06) 6.65 (1.38)
FIQ 65.53 (14.44) 61.83 (13.36) 59.73 (15.09)
PSQI 13.79 (2.95) 13.09 (3.79) 12.35 (3.76)
SF-physical 29.94 (8.30) 32.55 (8.82) 33.22 (8.36)
SF-mental 38.13 (9.62) 40.38 (10.08) 39.03 (11.03)
FIQ, fibromyalgia impact questionnaire; NRS-PI, numerical rating scale pain
intensity; PSQI, Pittsburgh Sleep Quality Index
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Figure 2 Effects of CFQ practice on pain, function and sleep. Change from baseline in (A) numerical rating scale-pain intensity (NRS-PI)
score, (B) fibromyalgia impact questionnaire (FIQ) score, and (C) Pittsburgh Sleep Quality Index (PSQI) scores in immediate and delayed qigong
practice groups compared to the wait-list/usual care control. Values are means for the (•) usual care, (◇) immediate practice, and (Δ) delayed
practice groups. Numbers at bottom of panels indicate mean (SD) values for respective groups. Between-group P-values indicated within figure.
B, baseline; mo, month.
Figure 3 Effects of CFQ practice on physical and mental function. Changes from baseline in (A) SF- physical, and (B) SF-mental scores in
immediate and delayed qigong practice groups compared to the wait-list/usual care control. Values are means for the (•) usual care, (◇)
immediate practice and (Δ) delayed practice groups. Numbers at bottom of panels indicate mean (SD) values for respective groups. Between-
group P-values indicated within the figure. B, baseline; mo, month.
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have been established. The number of individuals with a
≥ 2 point reduction in NRS-PI ranged from 38 to 51% in
the combined CFQ group, and this was significantly
higher than in the usual care group (9 to 18%) at all
times (Table 3A). Those with a ≥ 8.8 unit reduction in
FIQ scores ranged from 56 to 71% in the combined CFQ
group, and this was also significantly higher than in the
usual care group (20 to 34%) at all times (Table 3B). A
reduction in PSQI of ≥ 3 is considered a treatment effect
[26]. In the combined CFQ group, 48 to 51% attained
this, compared to 22 to 25% in the control group (Table
3C). In the CFQ group, 33 to 36% attained an increase of
≥ 6.5 points in SF-physical scores compared to 9 to 14%
in the control group; for SF-mental scores, 30 to 38% in
the CFQ group attained an increase of ≥ 7.9 points com-
pared to 11 to 27% in the control group (Table 3D, E).
These latter differences are considered clinically mean-
ingful in fibromyalgia [12].
Relationship of outcomes to extent of practice
The design of this trial included CFQ instruction and a
commitment to a minimum of 45 minutes daily
practice for eight weeks. We recognize this was a sig-
nificant commitment and that not all would be able to
meet this goal, despite best intentions. Self-reports of
weekly practice times indicated 38/73 (52%) practiced
for ≥ 5 h per week for this interval, which represents
per protocol practice. There was also a cohort
who completed training but then practiced minimally
(≤ 3 h/week) (N = 11/73; 15%). Figure 5 presents a
comparison of outcomes for those who adhered to the
protocol and those who practiced minimally. There
were significantly greater improvements in pain (six
months, Figure 5A), FIQ (two months, Figure 5B),
PSQI (two and four months, Figure 5C), physical func-
tion (four and six months, Figure 5D) and mental func-
tion (two months, Figure 5E) in the per protocol group.
Within the per protocol group, 53 to 57% had a ≥ 2
point reduction in NRS-PI, 60 to 82% had a reduction
of ≥ 8.8 units in FIQ, and 55 to 65% had a drop of ≥ 3
units in PSQI scores; furthermore, 37 to 43% had
increased SF-physical scores of ≥ 6.5 and 32 to 42%
had increased SF-mental scores of ≥ 7.9 over the six-
month duration of the study.
Figure 4 Mean differences from baseline for all participants who completed CFQ training and practice. (A) NRS-PI, (B) FIQ, (C) PSQI, (D)
SF- physical, (E) SF-mental scores. Numbers at bottom of panels indicate mean(SD) values for respective groups. Between-group P-values
indicated within figure. B, baseline; mo, month.
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Adverse events
Two participants experienced adverse events judged to
be possibly related to the CFQ practice. One patient
experienced an increase in right-sided shoulder pain,
and another participant experienced an episode of plan-
tar fasciitis. In both cases, patients were able to continue
with the study and the pain settled over time.
Discussion
The current randomized controlled trial demonstrates
that CFQ, a particular form of qigong, is potentially a
useful self-care practice for individuals with fibromyal-
gia. Improvements in pain, FIQ, sleep and physical and
mental function were observed using well-validated
measures, and improvements observed at the end of the
training and committed-practice interval were main-
tained in the longer term at four months and six
months. The design of this trial included two different
training cohorts separated by an interval of six months;
outcomes in both groups were similar over time and
this indicates the essential reproducibility of findings in
two different groups with fibromyalgia.
Results in this trial, where improvements in fibromyalgia
symptoms persist in the longer term for four to six
months, are generally consistent with recent controlled
trials of qigong [11] and tai chi [12], both of which are
regarded as “meditative movement” [13]. Each of these
studies attended to the need to engage in regular practice
following training, and report more robust improvements
than earlier trials where practice was limited [14-16]. With
these practices, the issue of how much practice is required
to see benefit (threshold effect) and to sustain benefit (pro-
duce long-term changes) requires attention. In the present
trial, significant and sustained benefits were observed in
the combined group even though only 38/73 (52%) of
those who completed the study self-reported practice as
per protocol for the initial eight weeks. A separate analysis
of those who actually completed per protocol practice (≥ 5
h/week) indicates a significantly greater improvement in
pain, FIQ, PSQI and physical and mental function at cer-
tain time intervals compared to those who engaged in
minimal practice. As with other forms of self-practice,
understanding the factors that determine motivation for
engaging in, and continuing with, self-practice will be
important for elaborating the potential for these techni-
ques to be of benefit for those with fibromyalgia.
There is a significant and emerging body of evidence for
health benefits of qigong and tai chi in a variety of condi-
tions [27]. These practices are complex, multi-component
interventions with inherent research challenges [28,29].
Both practices encompass two broad domains, movement
and mind-body approaches, and these domains potentially
can be considered separately. There is an extensive litera-
ture on exercise in fibromyalgia, and much of this (75% of
studies) emphasizes aerobic exercise and combined exer-
cise, strength and flexibility activity [30]. Meta-analyses
and systematic reviews indicate that exercise can provide
benefit in fibromyalgia, although there are differences in
conclusions relating to intensity of practice needed to
observe the benefit [6,31,32]. It is important to recognize
that the movement involved in CFQ, the form of qigong
evaluated in the present study, is loose and gentle and
does not involve aerobic elements, and may be fundamen-
tally different from aerobic exercise. There is also a
developing literature on mind-body practices, such as
mindfulness-based stress reduction (MBSR) and medita-
tion for fibromyalgia. Preliminary studies reported some
benefit in fibromyalgia using these approaches [33-35], but
a recent more extensive controlled trial reported limited
benefit with MBSR [36]. Comparative trials, in which
cohorts of patients undertake qigong versus exercise, or
qigong versus mind-body modalities, will be required in
order to ascertain whether qigong produces benefits that
differ from these other approaches.
Strengths and limitations of study
There are several notable features to this study, includ-
ing the recruitment of adequate numbers, the inclusion
of two cohorts (immediate, delayed training groups)
Table 3 Individuals with clinically meaningful
improvements
Variable Usual care Combined qigong P-value*
A. NRS-PI1
2 months 4/45 (8.9%) 36/76 (47.4%) P < 0.0001
4 months 7/44 (15.9%) 37/73 (50.7%) P = 0.0002
6 months 8/44 (18.2%) 28/73 (38.4%) P = 0.02
B. FIQ2
2 months 9/45 (20.0%) 53/75 (70.7%) P < 0.0001
4 months 13/44 (29.5%) 41/73 (56.2%) P = 0.005
6 months 15/44 (34.1%) 41/73 (56.2%) P = 0.02
C. PSQI3
2 months 11/45 (24.4%) 39/76 (51.3%) P = 0.004
4 months 10/44 (22.7%) 35/73 (47.9%) P = 0.007
6 months 11/44 (25.0%) 36/73 (49.3%) P = 0.01
D. SF-36 physical4
2 months 4/45 (8.9%) 27/76 (35.5%) P = 0.001
4 months 5/44 (11.4%) 24/73 (32.9%) P = 0.009
6 months 6/44 (13.6%) 24/73 (32.9%) P = 0.02
E. SF-36 mental4
2 months 5/45 (11.1%) 29/76 (38.2%) P = 0.001
4 months 6/44 (13.6%) 22/73 (30.1%) P = 0.05
6 months 12/44 (27.3%) 26/73 (35.6%) P = 0.35
* P-values calculated by using the chi-square test
1 Reduction of ≥ 2 points (30%) from baseline [21]
2 Reduction of ≥ 8.8 points or 14% from baseline [25]
3 Reduction of ≥ 3 PSQI points considered a treatment response [26]
4 Increase of 6.5 points (SF-physical) and 7.9 points (SF-mental) [12]
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which allows for assessment of reproducibility between
groups, the use of standardized measures to determine
outcomes, high follow-up rates for those who complete
training, long-term outcomes to six months, and atten-
tion to adherence to protocol with post-hoc analysis in
relation to the amount of practice. In addition, there is
also a consideration of those who attain outcomes that
are considered to represent clinically meaningful
changes. There are also limitations. (1) The study was
not blinded. With a complex intervention involving
movement and mind-body elements, it is not possible to
blind trials. Comparisons with other groups in which
specific elements are engaged are possible, and this may
be the most pragmatic approach for elaborating the
therapeutic potential of qigong for fibromyalgia. (2) The
control group was a wait-list group that underwent
usual care. As such, they did not receive attention or
engage in movement as did the intervention group, and
these elements may contribute to outcomes. Clinical
practice includes many non-specific elements which can
contribute to the overall efficacy of a treatment. With a
complex health condition, where symptoms persist
despite previous treatment regimes, the most relevant
consideration may be the number of patients who attain
clinically meaningful reductions in symptoms. Within
this study, significant numbers of those who completed
CFQ training and practice attained benchmarks both
when compared to the wait-list group, and when consid-
ered in absolute terms for the per protocol group. (3)
This study evaluated efficacy of qigong in those who
completed the study. The main study question was the
efficacy of CFQ for fibromyalgia over six months when
practiced diligently for eight weeks. A total of 81% of
both groups who undertook training completed the six-
month study, and this is a respectable rate of comple-
tion given practice requirements. The post-hoc analysis
in relation to the extent of practice indicates less benefit
was derived with minimal practice, so if one includes
those who did not complete the practice in the analysis,
a reduced effect would be observed. It is not possible to
evaluate the effect of a technique if it is not implemen-
ted, and other forms of analysis will not address the
essential study question. (4) This study examined one
particular form of qigong and the generalizability of
Figure 5 Comparison of outcomes in the per protocol practice group and those who practiced minimally. Values are means for those
who practiced minimally (≤ 3 h/week, N = 11), and those who practiced as per protocol (≥ 5 h/week, N = 38). Numbers at the bottom of the
figure indicate mean (SD) values. Between-group P-values indicated within figure. B, baseline; mo, month.
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results is not known. CFQ was elaborated and intro-
duced into North America in the 1990s [19]. There are
many forms of qigong, with references to hundreds of
different forms, as well as considerations of common
elements [13,27,37]. A study conducted in Sweden using
a different form of qigong has reported sustained benefi-
cial effects in fibromyalgia [11], and there are case
reports from the United States of benefits in fibromyal-
gia with external qigong [38]; these observations support
the involvement of common elements. Given the multi-
plicity of forms and their geographic representations,
research into the medical potential of qigong will need
to attend both to common elements, as well as to
exploring whether particular forms of qigong are more
effective than others.
Conclusion
Findings reported in this study indicate that self-practice
of CFQ, a particular form of qigong, leads to long-term
beneficial effects in fibromyalgia in several domains and
may be a useful adjunct in the management of fibro-
myalgia. Further study of the potential health benefits of
this modality is warranted.
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